Life sciences • Colorectal cancer
Geneoscopy, Inc. develops and commercializes RNA-based diagnostic tests for colorectal cancer and inflammatory bowel disease.
Biotech • Clinical-stage
Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.
AI-driven Clinical Management • Self-serve Clinical Solutions
AdaptX is a Seattle-based company that specializes in self-serve clinical management solutions, using AI-driven technology to assess and improve care across patients using data from electronic medical records.
Biotechnology • Gene Editing
Epigenic Therapeutics is a biotechnology company that develops gene editing therapies for various diseases using its proprietary technology platform, EPIREG, which optimizes CRISPR-Cas components for gene regulation without altering DNA sequences and employs a proprietary lipid nanoparticle medicine delivery system.